Mapi Pharma's Series B Round

Mapi Pharma raised a round of funding on August 17, 2017. Investors include aMoon Partners.

Mapi Pharma is a development stage pharmaceutical company, engaged in the development of high-barrier to entry and high-added value life cycle management ("LCM") products that target large markets and…

Articles about Mapi Pharma's Series B Round: